Paxlovid Becomes Household Name for Covid-19 Patients

Posted on AllSides May 30th, 2022
From The Center

The Covid-19 treatment from Pfizer Inc. has become the leading pandemic pill prescribed in the U.S., as supplies have improved and its availability at pharmacies widened.

Pfizer’s antiviral drug, called Paxlovid, totaled more than 412,000 prescriptions through May 6, compared with about 110,000 prescriptions of molnupiravir, an antiviral from Merck & Co. and Ridgeback Biotherapeutics LP, according to drug-data firm Iqvia Holdings Inc.

Both pills were cleared for use in high-risk individuals early in the course of their disease in December by the U.S. Food and Drug Administration, to keep people from becoming hospitalized.

While separate clinical trials showed...

Read full story
Some content from this outlet may be limited or behind a paywall.

Wall Street Journal (News)

AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
106731/84335
See full bias rating for Wall Street Journal (News)
Learn about media bias
https://www.wsj.com/articles/paxlovid-becomes-household-name-for-covid-19-patients-11653908400

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right